These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15388796)

  • 1. Somatostatin receptor subtype-dependent regulation of nitric oxide release: involvement of different intracellular pathways.
    Arena S; Pattarozzi A; Corsaro A; Schettini G; Florio T
    Mol Endocrinol; 2005 Jan; 19(1):255-67. PubMed ID: 15388796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of shear stress-induced endothelial nitric-oxide synthase phosphorylation and expression in ovine fetoplacental artery endothelial cells.
    Li Y; Zheng J; Bird IM; Magness RR
    Biol Reprod; 2004 Mar; 70(3):785-96. PubMed ID: 14627548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
    Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
    Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities.
    Florio T; Morini M; Villa V; Arena S; Corsaro A; Thellung S; Culler MD; Pfeffer U; Noonan DM; Schettini G; Albini A
    Endocrinology; 2003 Apr; 144(4):1574-84. PubMed ID: 12639942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin and its receptor family.
    Patel YC
    Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. nitric oxide triggers the phosphatidylinositol 3-kinase/Akt survival pathway in insulin-producing RINm5F cells by arousing Src to activate insulin receptor substrate-1.
    Tejedo JR; Cahuana GM; Ramírez R; Esbert M; Jiménez J; Sobrino F; Bedoya FJ
    Endocrinology; 2004 May; 145(5):2319-27. PubMed ID: 14764634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic fibroblast growth factor activates endothelial nitric-oxide synthase in CHO-K1 cells via the activation of ceramide synthesis.
    Florio T; Arena S; Pattarozzi A; Thellung S; Corsaro A; Villa V; Massa A; Diana F; Spoto G; Forcella S; Damonte G; Filocamo M; Benatti U; Schettini G
    Mol Pharmacol; 2003 Feb; 63(2):297-310. PubMed ID: 12527801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).
    Florio T; Yao H; Carey KD; Dillon TJ; Stork PJ
    Mol Endocrinol; 1999 Jan; 13(1):24-37. PubMed ID: 9892010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-intensity p38 kinase activity is critical for p21(cip1) induction and the antiproliferative function of G(i) protein-coupled receptors.
    Alderton F; Humphrey PP; Sellers LA
    Mol Pharmacol; 2001 May; 59(5):1119-28. PubMed ID: 11306695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide production stimulated by the basic fibroblast growth factor requires the synthesis of ceramide.
    Arena S; Pattarozzi A; Thellung S; Villa V; Corsaro A; Massa A; Diana F; Spoto G; Forcella S; Damonte G; Filocamo M; Benatti U; Schettini G; Florioa T
    Ann N Y Acad Sci; 2002 Nov; 973():94-104. PubMed ID: 12485842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.
    Sharma K; Patel YC; Srikant CB
    Mol Endocrinol; 1996 Dec; 10(12):1688-96. PubMed ID: 8961277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor activates endothelial nitric oxide synthase by Ca(2+)- and phosphoinositide 3-kinase/Akt-dependent phosphorylation in aortic endothelial cells.
    Makondo K; Kimura K; Kitamura N; Kitamura T; Yamaji D; Jung BD; Saito M
    Biochem J; 2003 Aug; 374(Pt 1):63-9. PubMed ID: 12757411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms.
    Buscail L; Estève JP; Saint-Laurent N; Bertrand V; Reisine T; O'Carroll AM; Bell GI; Schally AV; Vaysse N; Susini C
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1580-4. PubMed ID: 7878022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal nitric oxide synthase: a substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling.
    Lopez F; Ferjoux G; Cordelier P; Saint-Laurent N; Estève JP; Vaysse N; Buscail L; Susini C
    FASEB J; 2001 Oct; 15(12):2300-2. PubMed ID: 11511520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells.
    Federici M; Pandolfi A; De Filippis EA; Pellegrini G; Menghini R; Lauro D; Cardellini M; Romano M; Sesti G; Lauro R; Consoli A
    Circulation; 2004 Jan; 109(3):399-405. PubMed ID: 14707024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of somatostatin receptor 1 and 5 on epidermal growth factor receptor mediated signaling.
    Kharmate G; Rajput PS; Watt HL; Somvanshi RK; Chaudhari N; Qiu X; Kumar U
    Biochim Biophys Acta; 2011 Jun; 1813(6):1172-89. PubMed ID: 21419811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin preserved blood brain barrier against cytokine induced alterations: possible role in multiple sclerosis.
    Basivireddy J; Somvanshi RK; Romero IA; Weksler BB; Couraud PO; Oger J; Kumar U
    Biochem Pharmacol; 2013 Aug; 86(4):497-507. PubMed ID: 23770458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects.
    Stirone C; Boroujerdi A; Duckles SP; Krause DN
    Mol Pharmacol; 2005 Jan; 67(1):105-13. PubMed ID: 15496504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells.
    Montagnani M; Ravichandran LV; Chen H; Esposito DL; Quon MJ
    Mol Endocrinol; 2002 Aug; 16(8):1931-42. PubMed ID: 12145346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential involvement of signaling pathways in the regulation of growth hormone release by somatostatin and growth hormone-releasing hormone in orange-spotted grouper (Epinephelus coioides).
    Wang B; Qin C; Zhang C; Jia J; Sun C; Li W
    Mol Cell Endocrinol; 2014 Feb; 382(2):851-9. PubMed ID: 24183819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.